ArticleCancers2024
Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents.
Jan-Paul Bohn, Valentina Stolzlechner, Georg Göbel, Wolfgang Willenbacher, Markus Pirklbauer, Normann Steiner, Dominik Wolf
Abstract read
In one paragraphArticle in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Jan-Paul BohnDepartment of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Austrian Comprehensive Cancer Network (ACCN), Tyrolean Cancer Research Center (TKFI), Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-2066-7377 Valentina StolzlechnerDepartment of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Austrian Comprehensive Cancer Network (ACCN), Tyrolean Cancer Research Center (TKFI), Medical University of Innsbruck, 6020 Innsbruck, Austria.
Georg GöbelDepartment of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Wolfgang WillenbacherDepartment of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Austrian Comprehensive Cancer Network (ACCN), Tyrolean Cancer Research Center (TKFI), Medical University of Innsbruck, 6020 Innsbruck, Austria.
Markus PirklbauerDepartment of Internal Medicine IV, Nephrology and Hypertension, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-1211-0253 Normann SteinerDepartment of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Austrian Comprehensive Cancer Network (ACCN), Tyrolean Cancer Research Center (TKFI), Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-9829-1309 Dominik WolfDepartment of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Austrian Comprehensive Cancer Network (ACCN), Tyrolean Cancer Research Center (TKFI), Medical University of Innsbruck, 6020 Innsbruck, Austria.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
chronic lymphocytic leukemiaCLL-IPIprognosis
Identifiers
PMID39594701
PMCPMC11592300
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390